Status:
UNKNOWN
Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric Cancer
Lead Sponsor:
Lin Chen
Collaborating Sponsors:
Xijing Hospital
Conditions:
Gastric Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
Background: Although its incidence and mortality has decreased, gastric cancer (GC) is the fourth most common cancer and the second leading cause of cancer-related death worldwide, particularly in Ch...
Detailed Description
Late detection is a major reason for the poor prognosis of patients with gastric cancer. For example, the proportion of patients diagnosed with early gastric cancer is as low as 9% in China. The survi...
Eligibility Criteria
Inclusion
- Having signed informed consent
- Age≥ 18 years old
- Histologically confirmed gastric adenocarcinoma
Exclusion
- Other previous malignancy within 5 year
- Surgery (excluding diagnostic biopsy) within 4 weeks prior to study
- Pregnancy or lactation period
- Legal incapacity
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT05397548
Start Date
May 1 2022
End Date
December 1 2023
Last Update
June 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xinxin Wang
Beijing, Beijing Municipality, China, 100853